about
Proteomic and biomarker studies and neurological complications of pediatric sickle cell diseaseMetabolomics and systems pharmacology: why and how to model the human metabolic network for drug discoveryProteomic and other mass spectrometry based "omics" biomarker discovery and validation in pediatric venous thromboembolism and arterial ischemic stroke: current state, unmet needs, and future directions.Plasma Glial Fibrillary Acidic Protein, Copeptin, and Matrix Metalloproteinase-9 Concentrations among West African Stroke Subjects Compared with Stroke-Free Controls.Epigenetic patterns of two gene promoters (TNF-α and PON) in stroke considering obesity condition and dietary intake.Characterization of the rat cerebrospinal fluid proteome following acute cerebral ischemia using an aptamer-based proteomic technology.
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Potential blood biomarkers for stroke.
@en
type
label
Potential blood biomarkers for stroke.
@en
prefLabel
Potential blood biomarkers for stroke.
@en
P2093
P2860
P356
P1476
Potential blood biomarkers for stroke.
@en
P2093
Carlos M Laborde
Felix Gil-Dones
Fernando Vivanco
Finn Akerstrom
Laura Mourino-Alvarez
Luis R Padial
Maria G Barderas
P2860
P304
P356
10.1586/EPR.12.33
P577
2012-08-01T00:00:00Z